logo
Products
Technologies
Applications
Services
Resources
Selection Guides
About
PE/iFluor® 594 Anti-human CD38 Antibody
HI157
The HI157 monoclonal antibody binds to human CD38, a 45 kD transmembrane glycoprotein typically found on the surface of plasma cells, dendritic cells and myeloids. CD38 acts in important cellular pathways, in particular, the B cell receptor signaling pathway and apoptotic signaling pathway. Also, in many organisms, it acts to positively regulate vasoconstriction, acts to positively regulate cell growth and is a positive regulator of insulin secretion. From a research standpoint, it is of biological interest due to its association with essential macromolecules/ligands such as CD3/TcR complex, HLA Class II, Hyaluronic acid and CD31. CD38 is a fairly uncommon antibody target, with a little more than 10000 publications in the last decade. Even still, CD38 is often used in flow cytometry applications as a phenotypic marker for differentiation of cell types, specifically in the study of immunology. This antibody was purified through affinity chromatography and conjugated to PE/iFluor® 594 (ex/em = 566/606 nm). It is compatible with the 561 nm laser and 615/20 nm bandpass filter (for example, as in the Miltenyi Biotec MACSQuant VYB).
product image
product image
CatalogSize
Price
Quantity
103811Y025 tests
Price
103811Y1100 tests
Price
103811Y2500 tests
Price
 
Antibody properties

Other namesADP-ribosyl cyclase; T10
CloneHI157
Hostmouse
Isotypemouse IgG2a
Reactivityhuman
Spectral properties

Absorbance (nm)566
Extinction coefficient (cm -1 M -1)
1960000
Excitation (nm)565
Emission (nm)606
Storage, safety and handling

H-phraseH303, H313, H333
Hazard symbolXN
Intended useResearch Use Only (RUO)
R-phraseR20, R21, R22
Contact us

Telephone
Fax
Emailsales@aatbio.com
InternationalSee distributors
Bulk requestInquire
Custom sizeInquire
Technical SupportContact us
Request quotationRequest
Purchase orderSend to sales@aatbio.com
ShippingStandard overnight for United States, inquire for international
Page updated on October 9, 2025